The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Yeah all positive with EUDA. It was less than a dollar a few months back and has really lifted over the last week.
If something is a no then it is a no and often does not take long, it doesn't carry on for months unless they have been negotiating and working on a structure, legal work and negotiating completion. The chances are very good.
If it happens likely you double/triple or more with longer term gains being much higher from here. If it doesn't then even if we drop 20% then news on lab contracts or CLX or other news can take us comfortably past this level. Everything would have to fail for us to drop much lower imo.
Typo. Its been a long day/week/year
In other news its nice to be reading actual business updates and news rather than the usual guessing, arguing and back and forth. GLA to any invested.
2p. Wow. It's nearly $1.8 now. ;-)
Pretty sure EUDA was around 2p a year ago? We get your points without exaggerating them Porky, you've nearly convinced people don't start slipping...
Euda up 37% in the last 5 days. Let's hope its merger linked. Fingers crossed PM2022
65p and 74p with 201 results and when LOI signed. When Valirx had nothing but now it has so much. Cash burn remains low and enough until 2025.
Now the foundations are 10 times stronger. Projects from some of the best universities in the world that have had access to world class research facilities, world class staff and students. Some of the best research projects and it will attract attention from big pharmaceutical companies for an early deal. The problem is this will not be 4p then.
1) Nearterm revenue from the lab is very likely coming shortly.
2) 201 conclusion
3) CLX updates/deal
4) More evaluation projects.
5) Outcomes to evaluation projects.
6)401 outcome
Anything positive at this price will turn this big. Free ride for 201 here.
Well worth a punt at 4p imo. The upside vs downside is attractive now.
@PM2022
yeah and penny placing in July, highly likely, reduces your investment by another 75% from here.
AT 4p this is VERY expensive based on the current BODs expensive cash burn decisions
This situation can only change and improve once the dead wood is removed and new BOD in situ.
Meanwhile traders will continue to play with it whilst it remains totally uninvestable
8p doubles your money. With all the news due and a decent cash balance got to be confident of that.
All with a huge chance of 201 completing as well.
Work for nothing and you'll always be busy.
Does anyone else feel with the right CEO and industry connections VAL could fly?
That Theorem website gets worse with every development. They can't even update Dodgy Ken's profile pic with one that's in focus. Absolutely bobbins.
They will be looking at Ovarian according to the latest RNS. On Trx website that is an area they are specializing in too. The plot thickens....
The market cap of EUDA is 40 million dollars based on what exactly? IF it was 10 USD without dilution it would be valued at 300 million dollars. We are not looking at the share price of EUDA but market cap.
It was not the evaluation period of the merger but purely for due diligence. LEARN TO READ.
TRX would have raised cash which is why they are at this stage. It took time due to the other compounds and raising additional money.
The only part that matters is getting money owed to us and get 201 progressed.
1. SP of EUDA over a year is down from 10 USD to 1.60 USD. It has to remain over 1.45 USD otherwise it gets delisted. It’s bouncing around that price on VERY low volume by traders.
2 The evaluation period of the merger finished last year and was not nor did they mention in the subsequent update that talks were ongoing, they don’t need to advise the market further.
3. Confidence in the BOD regarding the handling of 201 is shot due to the appalling way it’s been handled. I’m not even going to list all the blunders, it’s been covered to death.
4. granted that THX would benefit merging with EUDA but EUDA could find a much better suitor. It’s been discussed to death; even as a merged entity THX would need to go on and try and raise cash with no guarantees. Any new legal entity created would need to renegotiate terms regarding the LOI from back in 2021 anyhow and finally as again already discussed the tech from 201 now being over 15 years old has likely been superseded anyhow not to mention it needs reformulating and a new patent as the last set of patents expired last year.
As per usual @PM2022 you are posting utter cack
First time for everything I suppose ;-)
Certainly hope you are correct my friend!
I heard it would likely be soon without a timeline given but not going to say my source. Pure guess but I think this month but either way it should not be far.
When, in your opinion do you think Euda/Trx merger will finish Pm? I think that is key, if that goes ahead 201 will get signed in my opinion. It's just all if's and but's until then though.
201 is needed for a higher share price and lower dilution in the future plus the extra money and milestones will attract investors. Otherwise you will be raising less money due to the market cap most likely at a lower price which would be risky moving forward.
The damage is done so now if it is close to completed then no question that is what should be done. It can reverse to the 15/20p mark with 201 and come lab contracts rather than a 2p or less placing in the future.
Adams posted on Twitter about 3 times in an hour about how amazing this RNS is. So, think he likes it haha.
NH...totally agree mate ..
The TheoremRx debacle has been a farce with SD continuing with it when I've said call a day after 3 years of trying to raise..maybe she's still confident and may well surprise us then this board may review their opinions.. its revenue which will drive the SP here and currently there's none
Along with all the secrecy of not naming the Japanese Co.and others it remains a guessing game .. I think clarity would help the company but everything's a secret ...At the moment a conclusion to theoremrx is the only thing to move us significantly. We wait in hope ..
Regards the req notice I'm.not sure about the role of observer by Ron .
Is this really going to help us ..an acting Headmaster and an extra wage we don't need... The patent guy was a good call. To be honest AH role as shareholder liaison was a waste of space and did what.. another role created where his actual knowledge and profession would have been far greater used if he was employed in a role in his field and able to contribute significantly. .
PJ
Pj, I'm of the opinion AIM has been f*cked by too many lifestyle CEO's pumping their SP's with any old dross over the last five years or so.
The market only responds to tangible metrics these days. Anything vaguely sounding like jam tomorrow is dismissed out of hand.
CLX and the new evaluations might make it incredibly appealing to a dynamic, commercially astute individual whom has the ambition to make a name for themselves in the Biotech sector.
Based on
1) Share price of EUDA
2) Still ongoing. IF it was a failure it would have been announced already. Mergers that complete often take months.
3) Continued confidence of BOD in 201.
4) Both EUDA and TRX need the merger to go ahead so no real reason for it to not go ahead.